Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Current pharmaceutical design 16 , 2103-2112 (2010)
Unlike people with bulimia (who also binge-eat), those with binge eating disorder do not engage in compensatory behaviors after binging
Additional safety considerations include: Acute pancreatitis risk : Patients should be monitored for severe abdominal pain Gallbladder disease : Including cholelithiasis and cholecystitis Dehydration and acute kidney injury : Particularly with gastrointestinal side effects Hypoglycemia : When used with insulin or sulfonylureas in patients with diabetes Diabetic retinopathy complications : Particularly with semaglutide in patients with pre-existing retinopathy Patients with hypothyroidism should undergo thyroid function monitoring when starting weight loss injections
After reconstitution, use immediately and then discard the pen
US$ 21.71
US$ 25.20
US$ 24.58
US$ 24.11
US$ 23.56
